Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PBLS compared with ALMS: revenue, margins and what each company keeps, and the suppliers and customers both name
PBLS
Parabilis Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
ALMS
Alumis Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PBLS
Parabilis Medicines, Inc.
vs
ALMS
Alumis Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PBLS: latest quarter is a loss; flow not drawable. ALMS: latest quarter is a loss; flow not drawable.
Method
›
PBLS
Parabilis Medicines, Inc.
Change
27.29
▲
+0.15%
· post 29.29
· delayed
Mkt cap
$787.8M
Revenue
$148,000
Q2 FY26
Revenue
—
ALMS
Alumis Inc.
Change
6.48
▲
+1.59%
· post 6.48
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$825.8M
Revenue
$2M
Q2 FY26
Revenue
$24M
FY25
vs
Compare
After hours
Nov 3 '26
delayed
PBLS
Parabilis Medicines, Inc.
vs
ALMS
Alumis Inc.
27.29
▲
+0.15%
post 29.29
delayed
Price
6.48
▲
+1.59%
post 6.48
delayed
$787.8M
Mkt cap
$825.8M
Q2 FY26
$148,000
Revenue
$2M
Q2 FY26
—
Revenue
$24M
FY25
Change
Change
PBLS
27.29
▲
+0.15%
vs
ALMS
6.48
▲
+1.59%
After hours
Nov 3 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PBLS, solid
ALMS, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PBLS
2
REGN
Regeneron Pharmaceuticals
customer
—
Alcami
unlisted
supplier
Shared
0
No shared counterparties.
Only ALMS
3
—
Pierre Fabre
unlisted
supplier
—
FronThera U.S
unlisted
supplier
—
Kaken
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR